AMED Past Earnings image   This AMED past earnings page last updated 5/23/2022
AMED Past Earnings
PeriodPast Earnings DateAdj. EPS
Q1 20224/27/20221.230
Q4 20212/23/20221.180
Q3 202111/2/20211.530
Q2 20218/4/20211.690
Q1 20214/28/20211.540
Q4 20202/24/20211.490
Q3 202010/28/20202.240
Q2 20207/28/20201.340
Q1 20205/6/20201.050
Q4 20192/18/20200.940
Q3 201910/29/20191.150
Q2 20197/31/20191.210
Q1 20194/30/20191.110
Q4 20182/27/20190.91
Q3 201810/29/20180.95
Q2 20187/31/20181
Q1 20185/7/20180.79
Q4 20172/27/20180.56
Q3 201711/7/20170.56
Q2 20177/26/20170.62
Q1 20175/2/20170.47
Q4 20162/28/20170.44
Q3 201611/3/20160.36
Q2 20168/2/20160.42
Q1 20165/3/20160.33
Q4 20153/9/20160.4
Q3 201511/5/20150.34
Q2 20157/29/20150.43
Q1 20154/29/20150.3
Q4 20143/4/20150.27
Q3 201410/29/20140.28
Q2 20147/30/20140.23
Q1 20145/8/2014-0.07
Q4 20133/12/2014-0.07
Q3 201311/12/2013-0.01
Q2 20137/31/20130.17
Q1 20134/30/20130.13
Q4 20123/12/20130.23
Q3 201211/6/20120.33
AMED Past Revenue
PeriodPast Earnings DateGAAP
Q1 20224/27/20220.55B
Q4 20212/23/20220.56B
Q3 202111/2/20210.55B
Q2 20218/4/20210.56B
Q1 20214/28/20210.54B
Q4 20202/24/20210.55B
Q3 202010/28/20200.54B
Q2 20207/28/20200.49B
Q1 20205/6/20200.49B
Q4 20192/18/20200.50B
Q3 201910/29/20190.49B
Q2 20197/31/20190.49B
Q1 20194/30/20190.47B
Q4 20182/27/2019434.38M
Q3 201810/29/2018417.33M
Q2 20187/31/2018411.60M
Q1 20185/7/2018399.26M
Q4 20172/27/2018404.24M
Q3 201711/7/2017380.16M
Q2 20177/26/2017378.82M
Q1 20175/2/2017370.46M
Q4 20162/28/2017365.15M
Q3 201611/3/2016361.60M
Q2 20168/2/2016361.69M
Q1 20165/3/2016348.82M
Q4 20153/9/2016337.31M
Q3 201511/5/2015326.45M
Q2 20157/29/2015314.15M
Q1 20154/29/2015301.57M
Q4 20143/4/2015300.53M
Q3 201410/29/2014300.28M
Q2 20147/30/2014243.50M
Q1 20145/8/2014298.74M
Q4 20133/12/2014303.49M
Q3 201311/12/2013301.64M
Q2 20137/31/2013313.15M
Q1 20134/30/2013273.60M
Q4 20123/12/2013362.90M
Q3 201211/6/2012375.60M
Quotes delayed 20 minutes

Email EnvelopeFree AMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Amedisys (AMED) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AMEH Historical Earnings
AMGN Historical Earnings
AMN Historical Earnings
AMPH Historical Earnings
AMRX Historical Earnings
AMTI Historical Earnings
ANAB Historical Earnings
ANGN Historical Earnings
ANGO Historical Earnings
ANIK Historical Earnings

AMED Past Earnings Q&A

What was the best and worst AMED past earnings results?
For Amedisys, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest AMED past earnings result in our data set was 2.240/share posted in Q3 2020, while the lowest was in Q1 2014 when AMED posted -0.07/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2021 when AMED reported 0.56B in revenue, while the quarter with the lowest revenue in our data set was Q2 2014 at 243.50M of revenue.

  Suggested answer: There are 39 AMED past earnings results in our data set.

On this page we presented the AMED past earnings date information for Amedisys. Reviewing that AMED Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when AMED posted adjusted EPS of 2.240/share. Meanwhile the lowest AMED past earnings result was in Q1 2014, when AMED posted adjusted EPS of -0.07/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2021 when AMED reported 0.56B in revenue, while the smallest revenue quarter was Q2 2014 when AMED reported 243.50M in revenue.

Any self directed investor doing their due diligence on AMED or any other given stock can benefit from researching all of the Amedisys past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Amedisys past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AMED. Thanks for visiting, and the next time you need to research AMED past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: ETFs Holding ATO, REC Split History, Institutional Holders of NCU.

 

AMED Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.